Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 18,836 | 15,401 | 14,409 | 40,659 | 7,978 |
| Cost of Goods | 7,125 | 5,075 | 5,558 | 1,800 | 1,784 |
| Gross Profit | 11,711 | 10,326 | 8,851 | 38,859 | 6,194 |
| Operating Expenses | 54,825 | 66,029 | 65,154 | 72,192 | 89,802 |
| Operating Income | -42,989 | -55,628 | -55,745 | -32,533 | -82,824 |
| Interest Expense | 14,062 | 13,430 | 13,654 | 11,144 | 8,125 |
| Other Income | 320 | 3,939 | 13 | 9 | 14 |
| Pre-tax Income | -56,731 | -65,119 | -69,386 | -43,668 | -90,935 |
| Net Income Continuous | -56,731 | -65,119 | -69,386 | -43,668 | -90,935 |
| Net Income | $-56,731 | $-65,119 | $-69,386 | $-43,668 | $-90,935 |
| EPS Basic Total Ops | -0.93 | -1.52 | -2.62 | -1.67 | -3.50 |
| EPS Basic Continuous Ops | -0.93 | -1.52 | -2.62 | -1.67 | -3.50 |
| EPS Diluted Total Ops | -0.93 | -1.52 | -2.62 | -1.67 | -3.50 |
| EPS Diluted Continuous Ops | -0.93 | -1.52 | -2.62 | -1.67 | -3.50 |
| EBITDA(a) | $-42,265 | $-55,056 | $-55,182 | $-31,976 | $-82,271 |